Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-12-06 Purchase | 2022-12-07 9:26 pm | LENSAR Inc. | LNSR | STAAB THOMAS R II Chief Financial Officer | 2,752 | $3.1604 | $8,697 | 135,131 (Direct) | View |
2019-05-16 Sale | 2019-05-20 4:21 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 9,750 | $7.6508 | $74,595 | 186,176 (Direct) | View |
2019-05-14 Sale | 2019-05-16 4:29 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 11,750 | $7.8051 | $91,710 | 266,426 (Direct) | View |
2019-05-09 Sale | 2019-05-13 4:57 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 19,500 | $7.695 | $150,053 | 404,926 (Direct) | View |
2019-05-02 Sale | 2019-05-06 4:51 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 16,750 | $7.5418 | $126,325 | 443,176 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-01-11 Option Award | 2023-01-13 5:29 pm | N/A 2033-01-11 | LENSAR Inc. | LNSR | STAAB THOMAS R II Chief Financial Officer | 29,951 | $0 | 165,082 (Direct) | View |
2022-01-11 Option Award | 2022-01-13 5:20 pm | N/A 2032-01-11 | LENSAR Inc. | LNSR | STAAB THOMAS R II Chief Financial Officer | 67,500 | $0 | 183,909 (Direct) | View |
2021-04-12 Option Award | 2021-04-14 09:00 am | N/A 2031-04-12 | LENSAR Inc. | LNSR | STAAB THOMAS R II Chief Financial Officer | 49,197 | $0 | 49,197 (Direct) | View |
2020-12-07 Option Award | 2020-12-10 8:50 pm | N/A N/A | LENSAR Inc. | LNSR | STAAB THOMAS R II Chief Financial Officer | 19,276 | $0 | 115,657 (Direct) | View |
Ownership | 2020-09-17 5:57 pm | N/A N/A | LENSAR Inc. | LNSR | STAAB THOMAS R II Chief Financial Officer | 0 | $0 | 96,381 (Direct) | View |
2020-02-21 Option Award | 2020-02-25 4:28 pm | 2020-02-21 2024-12-22 | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 18,000 | $0 | 18,000 (Direct) | View |
2020-02-14 Option Award | 2020-02-19 4:57 pm | 2020-02-14 2024-12-22 | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 31,500 | $0 | 31,500 (Direct) | View |
2019-12-17 Option Award(A) | 2019-12-26 5:09 pm | 2020-12-17 2029-12-17 | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 127,000 | $0 | 127,000 (Direct) | View |
2019-12-17 Option Award | 2019-12-19 5:36 pm | 2020-12-17 2029-12-17 | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 165,000 | $0 | 165,000 (Direct) | View |
2019-05-16 Exercise | 2019-05-20 4:21 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 4,750 | $1.42 | 186,176 (Direct) | View |
2019-05-16 Exercise | 2019-05-20 4:21 pm | 2014-01-01 2023-01-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 4,750 | $0 | 186,176 (Direct) | View |
2019-05-14 Exercise | 2019-05-16 4:29 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 9,250 | $1.42 | 266,426 (Direct) | View |
2019-05-14 Exercise | 2019-05-16 4:29 pm | 2014-01-01 2023-01-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 9,250 | $0 | 266,426 (Direct) | View |
2019-05-09 Exercise | 2019-05-13 4:57 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 19,500 | $5.51 | 404,926 (Direct) | View |
2019-05-09 Exercise | 2019-05-13 4:57 pm | 2018-02-27 2027-02-27 | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 19,500 | $0 | 404,926 (Direct) | View |
2019-05-02 Exercise | 2019-05-06 4:51 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 16,750 | $5.51 | 443,176 (Direct) | View |
2019-05-02 Exercise | 2019-05-06 4:51 pm | 2018-02-27 2027-02-27 | BIOCRYST PHARMACEUTICALS INC | BCRX | STAAB THOMAS R II Senior Vice President and CFO | 16,750 | $0 | 443,176 (Direct) | View |